Bluejay Diagnostics Inc (BJDX) Financials
$1.03
As on 08-Sep-2026 16:29EDT
Market cap
$1 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0.1
Div. Yield
0 %
Income Statement ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
--
|
--
|
--
|
--
|
0.25
|
0.00
|
|||||
|
Cost of Revenue
|
0.13
|
0.17
|
0.20
|
0.78
|
0.20
|
0.15
|
|||||
|
Gross Profit
|
-0.13
|
-0.17
|
-0.20
|
-0.78
|
0.05
|
-0.15
|
|||||
|
Operating Expenses
|
7.27
|
6.95
|
7.17
|
10.31
|
9.37
|
3.23
|
|||||
|
Operating Profit (EBIT)
|
-7.36
|
-6.95
|
-7.17
|
-10.31
|
-9.32
|
-3.23
|
|||||
|
Other Income
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Profit before Tax
|
-7.27
|
-6.85
|
-7.72
|
-9.95
|
-9.30
|
-3.49
|
|||||
|
Provision for Tax
|
--
|
--
|
--
|
0.00
|
-0.07
|
0.24
|
|||||
|
Profit after Tax (Net Income)
|
-7.27
|
-6.85
|
-7.72
|
-9.95
|
-9.30
|
-3.73
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Consolidated Profit
|
--
|
--
|
--
|
--
|
-9.30
|
-3.49
|
Liabilities ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
9.41
|
5.98
|
5.73
|
2.89
|
11.54
|
20.38
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Non-Current Liabilities
|
0.00
|
0.02
|
0.12
|
0.20
|
0.34
|
--
|
|||||
|
Current Liabilities
|
2.12
|
1.12
|
0.81
|
1.77
|
1.64
|
0.64
|
|||||
|
Total Liabilities
|
13.65
|
7.12
|
6.66
|
4.87
|
13.52
|
21.02
|
Assets ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
1.72
|
1.66
|
1.76
|
1.65
|
1.73
|
0.36
|
|||||
|
Current Assets
|
9.81
|
5.46
|
4.90
|
3.22
|
11.79
|
20.66
|
|||||
|
Total Assets
|
13.65
|
7.12
|
6.66
|
4.87
|
13.52
|
21.02
|
|||||
|
Total Debt*
|
0.08
|
0.12
|
0.22
|
0.35
|
0.49
|
--
|
|||||
|
Net Current Assets
|
7.70
|
4.34
|
4.09
|
1.45
|
10.15
|
20.02
|
Cashflow ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
-6.05
|
-7.82
|
-8.31
|
-7.74
|
-4.37
|
|||||
|
Cash Flow from Investing Activities
|
--
|
-0.17
|
-0.31
|
-0.70
|
-1.20
|
-0.02
|
|||||
|
Cash from Financing Activities
|
--
|
7.09
|
10.22
|
1.11
|
0.01
|
22.53
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
--
|
--
|
--
|
--
|
--
|
Financials Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS ($)
|
-12.64
|
-15.25
|
-192.46
|
-257.21
|
-294.21
|
-118.78
|
|||||
|
Cash EPS ($)
|
--
|
-14.87
|
-187.50
|
-236.70
|
-284.51
|
-114.14
|
|||||
|
Adjusted Book Value ($)
|
--
|
13.31
|
142.88
|
74.80
|
365.23
|
649.10
|
|||||
|
Dividend per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow per Share ($)
|
--
|
-13.48
|
-195.01
|
-214.83
|
-244.99
|
-139.07
|
|||||
|
Free Cash Flow per Share ($)
|
--
|
-13.87
|
-202.66
|
-233.02
|
-282.94
|
-139.83
|
Profitability Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
-113.69
|
-167.79
|
-130.27
|
-57.36
|
-43.29
|
|||||
|
ROE (%)
|
-94.49
|
-117.02
|
-178.98
|
-137.90
|
-58.25
|
-46.12
|
|||||
|
ROA (%)
|
-68.93
|
-99.42
|
-133.92
|
-108.25
|
-53.83
|
-33.10
|
|||||
|
EBIT Margin (%)
|
--
|
--
|
--
|
--
|
-3,733.11
|
-4,161,118.67
|
|||||
|
Net Margin (%)
|
--
|
--
|
--
|
--
|
-3,733.11
|
-4,972,914.67
|
|||||
|
Cash Profit Margin (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
Growth Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
--
|
--
|
--
|
-1.00
|
3,319.53
|
--
|
|||||
|
EBIT Growth (%)
|
24.41
|
0.68
|
30.73
|
-7.07
|
-197.90
|
-160.85
|
|||||
|
Net Profit Growth (%)
|
-7.95
|
11.26
|
22.46
|
-7.07
|
-149.27
|
-231.32
|
|||||
|
EPS Growth (%)
|
89.88
|
0.92
|
0.25
|
0.13
|
-1.48
|
-1.09
|
|||||
|
Book Value Growth (%)
|
-70.32
|
--
|
--
|
--
|
--
|
--
|
Valuation Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
--
|
-0.04
|
-0.03
|
0.00
|
0.00
|
-0.02
|
|||||
|
Price / Book Value
|
0.09
|
0.05
|
0.03
|
0.02
|
0.00
|
0.00
|
|||||
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EV/EBITDA
|
-0.10
|
0.71
|
0.58
|
0.20
|
1.07
|
6.38
|
|||||
|
Close Price ($)
|
1.20
|
2.67
|
19.48
|
1,952.00
|
12,156.80
|
81,920.00
|
|||||
|
High Price ($)
|
16.68
|
40.80
|
1,952.00
|
28,160.00
|
102,400.00
|
200,000.00
|
|||||
|
Low Price ($)
|
1.05
|
2.53
|
12.12
|
1,873.28
|
8,892.80
|
71,040.00
|
|||||
|
Market Cap ($ Cr)
|
0.86
|
--
|
--
|
--
|
--
|
--
|
Solvency Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
--
|
0.02
|
0.04
|
0.12
|
0.04
|
--
|
|||||
|
Short term debt to equity ratio
|
0.01
|
0.02
|
0.02
|
0.06
|
0.01
|
--
|
|||||
|
Current Ratio
|
4.64
|
4.88
|
6.05
|
1.82
|
7.19
|
32.43
|
|||||
|
Quick Ratio
|
4.64
|
--
|
--
|
--
|
--
|
32.43
|
|||||
|
Interest Coverage
|
-18,786.33
|
-8,161.67
|
-8.38
|
--
|
-446.37
|
-8.49
|
Operating Efficiency Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Asset Turnover
|
--
|
--
|
--
|
--
|
0.01
|
0.00
|
|||||
|
Receivable days
|
--
|
--
|
--
|
--
|
--
|
38,789.55
|
|||||
|
Inventory Days
|
--
|
--
|
--
|
--
|
--
|
106.23
|
|||||
|
Payable days
|
--
|
384.53
|
583.93
|
263.62
|
850.12
|
840.57
|
|||||
|
Cash Conversion Cycle
|
--
|
--
|
--
|
--
|
--
|
38,055.20
|